Studies indicate that DHL attenuates pulmonary fibrosis in a bleomycin-induced mouse model by reducing TLR4 expression and inhibiting JNK and p38 MAPK signaling pathways [48]. The gene discussed is MAPK8; the disease is pulmonary fibrosis.